This article has Open Peer Review reports available.
How old are you, really? Communicating chronic risk through ‘effective age’ of your body and organs
© The Author(s). 2016
Received: 5 December 2015
Accepted: 28 July 2016
Published: 5 August 2016
In communicating chronic risks, there is increasing use of a metaphor that can be termed ‘effective-age’: the age of a ‘healthy’ person who has the same risk profile as the individual in question. Popular measures include ‘real-age’, ‘heart-age’, ‘lung-age’ and so on.
Here we formally define this concept, and illustrate its use in a variety of areas. We explore conditions under which the years lost or gained that are associated with exposure to risk factors depends neither on current chronological age, nor the period over which the risk is defined. These conditions generally hold for all-cause adult mortality, which enables a simple and vivid translation from hazard-ratios to years lost or gained off chronological age. Finally we consider the attractiveness and impact of this concept.
Under reasonable assumptions, the risks associated with specific behaviours can be expressed in terms of years gained or lost off your effective age. The idea of effective age appears a useful and attractive metaphor to vividly communicate risks to individuals.
KeywordsRisk communication Real age Heart age Lung age Hazard ratio
Communicating statistical risk information plays a vital part in the process of shared-care and informed health choices, whether using patient decision-aids or in more informal dialogue with health professionals. There has been recent guidance on communication tools for the risks of treatment outcomes , but these measures are concerned with the chances of events occurring within a fixed time period, say death following surgery.
Communicating chronic risks, associated with an increased chance event of an adverse event throughout the whole life-course, is more complex. The standard measure used by epidemiologists is the ‘hazard ratio’, which is the increased instantaneous risk associated with exposure to the risk factor, but this is a ‘relative risk’ measure that is known to produce an exaggerated impression .
An increasingly popular alternative is to assess what we shall call the ‘effective age’ of either a whole person or a particular organ. Many different terms are used for this metaphor: for example, websites will tell you your ‘real age’  your ‘health age’ , ‘vitality age’ , or ‘biological age’  (although the basis for these calculations is unclear), while your ‘Ubble Age’  is that of people of the same gender whose mean risk of dying in the next 5 years matches your risk. You can also, if you wish, obtain your ‘heart age’ , ‘lung age’ , or ‘brain age’ .
In each case an individual enters various characteristics of their health and habits, and their effective age is calculated. The idea is to allow people to compare their effective age with their chronological age, and hence provide a vivid idea of their state of health. One aim is to motivate them to reduce an increased effective age by either changing their behaviour or taking medical interventions.
Here we define precisely what is meant by effective age, give examples of its use as a communication tool, and relate it to previous work on ‘risk advancement periods’. The difference between an individual’s effective and chronological age is an attractive measure of either premature ageing or continued youthfulness, and we derive conditions under which this difference is independent of both chronological age and the horizon over which the risk is measured. Finally, we summarise experience of the impact of this metaphor, and consider its future use.
The meaning of ‘effective age’
Given a specified measure of ‘risk’, your effective age can be defined as the age of a typical ‘healthy’ person who matches your risk profile. So if your chronological age is 50, but your effective age is 60, this means that you are in the same risk category as a 60-year old who has ‘healthy’ risk factors, or at least the ones that are potentially modifiable.
The UK National Health Service Heart Age , based on the JBS3 calculator : this is the age of a someone of the same gender who has healthy risk factors and a matching annual risk of heart attack or stroke.
The UK Heart Age calculator  and QRISK2  calculate the age of a person with healthy risk factors and the same 10-year cardiovascular risk (assuming no deaths from other causes during this period).
The New Zealand ‘Know your Numbers’  program provides the age of someone with matching 5-year cardiovascular risk (again assuming no deaths from other causes during this period).
The concept of lung-age was developed over 30 years ago : using updated equations, calculators  derive the age for which your lung function results would be expected in a typical person of your age and height.
There are two crucial decisions in defining an effective age. The first is the specification of a ‘healthy’ person: for example, the Heart Age calculator on NHS Choices  uses a person of the same gender and ethnicity, and who is a non-smoker with no clinical conditions, a BMI of 26, systolic blood pressure 120, and LDL/HDL cholesterol ratio of 3.5. This choice of a ‘standard’ individual can have a major impact on the properties of the procedure. The ‘Ubble age’ calculator , based on nearly 500,000 UK Biobank participants , uses the population 5-year all-cause mortality as the reference level, but most of this risk comes from the few individuals who are already sick, and so greatly overestimates the risk of the vast majority of the population: it is one of those anomalous situations where nearly everyone is less than average. The consequence is that almost everyone’s Ubble age is considerably less than their chronological age – often around 10 years. In this case a better comparator may have been the 5-year all-cause mortality of a healthy population, or the median rather than mean risk.
The second decision is the choice of risk measure, and in particular whether it represents an instantaneous risk or ‘hazard’, or is defined as the chance of an adverse event of a fixed horizon, say 10 years. There is a strong relation to the work of Brenner and colleagues , who consider the difference between a person’s effective age (although they do not use this term) and their chronological age as advancing the time that they may suffer an adverse event, which they call an ‘advancement period’. If the risk is an ‘instantaneous’ measure, they term this a ‘rate advancement period’, and if it is a risk over a fixed horizon, say the chance of developing cancer in the next 10 years, they term this a ‘risk advancement period’.
For example, Liese and colleagues  used Rate Advancement Periods (RAPs) to communicate increased heart-attack risk from hypertension (RAP = 8 years) and smoking (RAP =11 years): the latter says that, compared with never/former smokers, smokers are expected to advance their risk of myocardial infarction approximately 11 years.
When can we ignore your current age and the risk horizon?
The difference between effective and chronological age could be called the ‘years lost/gained’ - for example if you are 50 years old, but your effective age is 60, you have ‘lost’ 10 years. It would be attractive if this difference did not depend on chronological age, so individuals could be told how specific behaviours added or subtracted so many years from their effective age: for example, that smoking 20 a day added 8 years to your effective age, however old you are at the moment.
Thus under these conditions the ‘risk advancement period’ t 1 − t 0 = b/c does not depend on the chronological age t 0.
We’ve also seen that, for example, different versions of ‘heart-age’ can depend on your risk of a heart attack this year, over the next 5 years, or the next 10 years. It would be desirable if this risk ‘horizon’ were irrelevant.
Condition 1. There are ‘proportional hazards’: i.e. risk factors act on the baseline trajectory by increasing the annual risk by a percentage that does not depend on current age.
Condition 2. The instantaneous risk (hazard) of a healthy person increases exponentially with age, i.e. each year increases the risk by a fixed percentage.
Thus e b and e c are the hazard ratios associated with a unit increase in the risk factor, and a year of ageing, respectively.
Fortunately these two conditions are reasonably plausible in a wide range of situations. The first condition is the standard assumption in the Cox regression model used widely in epidemiological studies, while we now show that the second condition of an exponentially-increasing hazard can be assumed to hold over a wide age-range, at least for all-cause mortality.
We note the steep decline once one has survived early childhood, to a minimum of less than 1 in 10,000 at around 10 years old (in spite of the anxieties expressed about vulnerable children, nobody in the history of humanity has been as safe as a modern Western 10-year-old). Then, apart from a ‘risk-taking’ bulge between 15 and 25, particularly in young men, there is a reasonably straight line until around 95. This linear growth on a logarithmic scale corresponds to an exponential growth in annual hazard, meaning the risk of dying each year increases by a fixed proportion for each year we age, exactly the condition we seek.
The relationship between specific behaviours and effective age
We now show that, given the two conditions of proportional and exponentially increasing hazards, we obtain an elegantly simple way of converting the estimated effects associated with different exposures to years of life lost or gained.
Hazard ratios (r) associated with specific behaviours derived from recent epidemiological studies, translated into ‘changes in effective age’ (t) through the formula t ≈ 10 ln(r)
Estimated hazard ratio r
Change in effective age if behaviour present (years)
Smoking 20 cigarettes a day
Eating 50 g processed meat a day
Watching 2 h of TV a day
An extra 5 units of BMI (Kg/m2) above 25.
Minimal exercise (compared to inactivity)
Further exercise (compared to minimal)
Eating fruit and vegetables (per 2 portions a day)
Taking statins (higher-risk patients)
There are three important caveats. Confronted with Table 1, the immediate temptation is to start adding the effects of the relevant exposures to get an overall number of years lost or gained. This assumes the values are all valid simultaneously, which would be true, for example, if all the hazard ratios had been calculated from a single Cox regression analysis with no interactions, However, combinations of estimates from different studies may not be too misleading provided the exposures are clearly distinct. This means there could be a reasonably sound basis for the sort of ‘real-age’ calculations shown on websites, although in practice the numbers used may often be more guesswork than based on the latest epidemiology.
Second, there must also be caution over any causal interpretation and assumption of reversibility – we should not casually say that changing behaviour will ‘take years’ off your age unless based on randomised evidence.
Finally, while we have argued that these two conditions hold for all-cause mortality, organ-specific effective age calculators are derived from other metrics such as the risk of cardiovascular events in current heart age calculators. These calculators assume a proportional hazard model and so the first condition holds, and the annual risk of cardiovascular events, while not specifically assumed to be exponential, will be strongly correlated with the risk of all-cause mortality. Thus the two conditions should roughly hold, and so the shift in effective age should be approximately independent of chronological age.
As a check, raised risk factors entered into QRISK2 that raised a chronological age of 60 to a ‘QRISK Healthy Heart Age’ of 64 were found to produce a similar difference of either 3 or 4 years when the chronological age was varied between 30 and 80.
The impact of communicating effective age
Concepts such as effective age are clearly attractive and even gripping metaphors: a journalist recently listed the ‘age’ of each of their organs , and it is claimed that 27,000,000 people have been provided with their Real Age.
There is also some evidence that these ideas might help change behaviour and improve risk factors. A recent review  claims that vascular age is easily understood by patients and has a greater impact on care than presenting an estimated cardio-vascular disease risk score, citing a study  in which Heart Age “was more emotionally impactful in those participants at higher actual CVD risk levels”. A trial  randomised over 3000 subjects to either conventional medical advice, a risk score or Heart Age, and found that levels of metabolic parameters had improved significantly after 12 months of follow-up in both risk communication groups, but more in the group randomised to receive their Heart Age. Heart age had increased in the control group and decreased in the intervention groups.
For ‘lung age’, the Step2quit study  found double the quit-rates in smokers who were told their lung age (6 % vs 14 %), and this led to recommendations  to routinely use this concept. However a study  of 144 smokers cast doubt on the ability of lung-age to increase motivation, while it’s been suggested that the concept may even reduce motivation to quit for those with a ‘normal’ lung age .
Appropriate methods for communicating risk information is a subject of intense current interest , but attention tends to focus on risks expressed as simple probabilities of adverse events. Chronic risks that influence long-term outcomes are more complex. This points to the need for randomised trials of alternative methods of providing chronic risk information, for example in comparison with other metaphors such as hazard ratios, changes in life-expectancy, and time lost per exposure, for example losing 15 min off your life expectancy for each cigarette .
The idea of behaviours being associated with adding or subtracting years from your effective age is clearly attractive to many people, and we have shown that these quantities can be made rigorous under plausible assumptions. Concepts based on the idea of effective age, such as Heart Age, are likely to become an increasingly familiar part of the discourse around risk and behaviour.
JBS3, Joint British Societies’ Recommendations on the Prevention of Cardiovascular Disease (3rd edition); RAP, rate advancement period
I am very grateful to David Harding for his continued support and encouragement.
The author’s post is endowed by the David and Claudia Harding Foundation.
Availability of data and materials
Mortality data in Fig. 2 is available from http://www.ons.gov.uk/ons/rel/lifetables/interim-life-tables/2010-2012/stbilt2012.html.
DS carried out all the research.
Consent for publication
Ethics approval and consent to participate
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Trevena LJ, Zikmund-Fisher BJ, Edwards A, Gaissmaier W, Galesic M, Han PKJ, et al. Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers. BMC Med Inform Decis Mak. 2013;13 Suppl 2:S7.View ArticlePubMedPubMed CentralGoogle Scholar
- The Dr. Oz Show. RealAge [Internet]. [cited 2015 Dec 3]. Available from: https://auth.doctoroz.com/realage.
- PreventDisease.com. Health Age and Life Expectancy [Internet]. [cited 2015 Dec 3]. Available from: http://preventdisease.com/healthtools/articles/health_age.shtml.
- Vitality Age. Vitality Age - Your details [Internet]. [cited 2015 Dec 3]. Available from: https://www.vitalityage.co.uk/.
- Health Life Vitality [Internet]. [cited 2015 Dec 3]. Available from: http://www.healthlifevitality.co.nz/bioage.html.
- Ganna A, Ingelsson E. Calculate your Ubble age [Internet]. UK Longevity Explorer (UbbLE). [cited 2015 Dec 3]. Available from: http://ubble.co.uk.
- NHS Health Check - NHS Choices. Heart age calculator [Internet]. [cited 2015 Dec 3]. Available from: https://www.nhs.uk/conditions/nhs-health-check/pages/check-your-heart-age-tool.aspx.
- Lung Age For Smoking Cessation [Internet]. [cited 2015 Dec 3]. Available from: http://www.chestx-ray.com/index.php/calculators/lung-age-for-smoking-cessation.
- Mail Online. Try test that reveals your brain age and read how to knock years off [Internet]. Mail Online. [cited 2015 Dec 3]. Available from: http://www.dailymail.co.uk/health/article-2821157/Try-test-reveals-brain-age-read-knock-years-it.html.
- Groenewegen K, den Ruijter H, Pasterkamp G, Polak J, Bots M, Peters SA. Vascular age to determine cardiovascular disease risk: a systematic review of its concepts, definitions, and clinical applications. Eur J Prev Cardiol. 2016;23(3):264–74.View ArticlePubMedGoogle Scholar
- JBS3 Risk Calculator [Internet]. [cited 2015 Dec 3]. Available from: http://www.jbs3risk.com/.
- ukheartage.co.uk. Is your Heart Age older than you? [Internet]. [cited 2015 Dec 3]. Available from: http://www.ukheartage.co.uk/.
- QRISK2-2015 [Internet]. [cited 2015 Dec 3]. Available from: http://www.qrisk.org/.
- Know Your Numbers. About Your Heart Age Forecast [Internet]. [cited 2015 Dec 3]. Available from: http://www.knowyournumbers.co.nz/your-heart-age-forecast.aspx.
- Morris JF, Temple W. Spirometric “lung age” estimation for motivating smoking cessation. Prev Med. 1985;14(5):655–62.View ArticlePubMedGoogle Scholar
- Ganna A, Ingelsson E. 5 year mortality predictors in 498 103 UK Biobank participants: a prospective population-based study. Lancet. 2015;386(9993):533–40.View ArticlePubMedGoogle Scholar
- Brenner H, Gefeller O, Greenland S. Risk and rate advancement periods as measures of exposure impact on the occurrence of chronic diseases. Epidemiol Camb Mass. 1993;4(3):229–36.View ArticleGoogle Scholar
- Liese AD. Assessing the impact of classical risk factors on myocardial infarction by rate advancement periods. Am J Epidemiol. 2000;152(9):884–8.View ArticlePubMedGoogle Scholar
- Office for National Statistics. Interim Life Tables, England and Wales, 2010–2012 [Internet]. 2013 [cited 2015 Dec 3]. Available from: http://www.ons.gov.uk/ons/rel/lifetables/interim-life-tables/2010-2012/stbilt2012.html.
- Gompertz B. On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies. Philos Trans R Soc Lond. 1825;115:513–83.View ArticleGoogle Scholar
- Vaupel JW. Biodemography of human ageing. Nature. 2010;464(7288):536–42.View ArticlePubMedPubMed CentralGoogle Scholar
- Daily Mail Online. I am 38. My heart is only 33, but my lungs are aged 52. Why? [Internet]. [cited 2015 Dec 3]. Available from: http://www.dailymail.co.uk/health/article-1249009/I-38-My-heart-only33-lungs-aged-52-Why.html.
- Soureti A, Hurling R, Murray P, van Mechelen W, Cobain M. Evaluation of a cardiovascular disease risk assessment tool for the promotion of healthier lifestyles. Eur J Cardiovasc Prev Rehabil. 2010;17(5):519–23.View ArticlePubMedGoogle Scholar
- Lopez-Gonzalez AA, Aguilo A, Frontera M, Bennasar-Veny M, Campos I, Vicente-Herrero T, et al. Effectiveness of the Heart Age tool for improving modifiable cardiovascular risk factors in a Southern European population: a randomized trial. Eur J Prev Cardiol. 2015;22(3):389–96.View ArticlePubMedGoogle Scholar
- Parkes G, Greenhalgh T, Griffin M, Dent R. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ. 2008;336(7644):598–600.View ArticlePubMedPubMed CentralGoogle Scholar
- Deane K, Stevermer JJ, Hickner J. Help smokers quit: tell them their “lung age”. J Fam Pract. 2008;57(9):584–6.PubMedPubMed CentralGoogle Scholar
- Lyna P, McBride C, Samsa G, Pollak KI. Exploring the association between perceived risks of smoking and benefits to quitting: Who does not see the link? Addict Behav. 2002;27(2):293–307.View ArticlePubMedGoogle Scholar
- Kaminsky DA, Marcy T, Dorwaldt A, Pinckney R, DeSarno M, Solomon L, et al. Motivating smokers in the hospital pulmonary function laboratory to quit smoking by use of the lung age concept. Nicotine Tob Res. 2011;13(11):1161–6.View ArticlePubMedPubMed CentralGoogle Scholar
- Spiegelhalter D. Using speed of ageing and “microlives” to communicate the effects of lifetime habits and environment. BMJ. 2012;345:e8223.View ArticlePubMedGoogle Scholar
- Doll R. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ. 2004;328:1519.View ArticlePubMedPubMed CentralGoogle Scholar
- Rohrmann S, Overvad K, Bueno-de-Mesquita HB, Jakobsen MU, Egeberg R, Tjønneland A, et al. Meat consumption and mortality - results from the European Prospective Investigation into Cancer and Nutrition. BMC Med. 2013;11(1):63.View ArticlePubMedPubMed CentralGoogle Scholar
- Wijndaele K, Brage S, Besson H, Khaw K-T, Sharp SJ, Luben R, et al. Television viewing time independently predicts all-cause and cardiovascular mortality: the EPIC Norfolk Study. Int J Epidemiol. 2011;40(1):150–9.View ArticlePubMedGoogle Scholar
- Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083–96.View ArticlePubMed CentralGoogle Scholar
- Ekelund U, Ward HA, Norat T, Luan J’a, May AM, Weiderpass E, et al. Physical activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women: the European Prospective Investigation into Cancer and Nutrition Study (EPIC). Am J Clin Nutr. 2015;101(3):613–21.View ArticlePubMedPubMed CentralGoogle Scholar
- Wang X, Ouyang Y, Liu J, Zhu M, Zhao G, Bao W, et al. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose–response meta-analysis of prospective cohort studies. BMJ. 2014;349:g4490.View ArticlePubMedPubMed CentralGoogle Scholar
- Ray KK, Seshasai SRK, Erqou S, Sever P, Jukema JW, Ford I, et al. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. Arch Intern Med. 2010;170(12):1024–31.View ArticlePubMedGoogle Scholar